Fei Chen joined TBG in 2008 and is primarily engaged in private placement and M&A transaction advisory in the healthcare and biotech sectors. He served as an intern at Vivo Ventures, a U.S. venture capital firm and Monitor, a U.S. consulting firm.

Mr. Chen earned his doctorate in medical and molecular biology from Fudan University and his bachelor’s degree in biology from Fudan University.